Christopher Kenney
Direttore Tecnico/Scientifico/R&S presso XENON PHARMACEUTICALS INC.
Patrimonio netto: - $ in data 30/06/2024
Relazioni attive
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Ian Mortimer | M | 48 | 11 anni | |
| Clarence Machado | M | 60 | 4 anni | |
| Dawn Svoronos | F | 70 | 8 anni | |
| Sherry Aulin | F | 41 | 13 anni | |
| Elizabeth Garofalo | M | 66 | 3 anni | |
| Andrea DiFabio | F | 55 | 2 anni | |
| Jodi Regts | F | - | 9 anni | |
| Gary Patou | M | 65 | 20 anni | |
| Steven Gannon | M | 62 | 9 anni | |
| Robin Sherrington | M | 63 | 23 anni | |
| Justin Gover | M | 53 | 1 anni | |
| Shelley McCloskey | F | 64 | 5 anni | |
| James Empfield | M | - | 8 anni | |
| Sheila M. Grant | F | - | 4 anni | |
| Christopher von Seggern | M | 45 | 4 anni | |
| Gillian Cannon | M | 60 | 1 anni | |
| Michael Rogawski | M | - | - |
Grafico relazionale
Relazione in diverse aziende
Relazioni precedenti
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Simon Pimstone | M | 56 | 28 anni | |
| Michael Hayden | M | 72 | 26 anni | |
| Adrian L. Rabinowicz | M | - | 6 anni | |
| Mohammad Azab | M | 68 | 21 anni | |
| Dave Grayzel | M | 56 |
Cadent Therapeutics, Inc.
 Cadent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Cadent Therapeutics, Inc. develops novel small molecule therapeutics to treat schizophrenia and other cognitive disorders. It focuses on modulating synaptic plasticity, the mechanism through which the brain builds and evolves the synaptic networks that carry out cognitive functions such as learning and memory. The company was founded by Kollol Pal, Frank S. Menniti, and Bertrand Leo Chenard in 2010 and is headquartered in Cambridge, MA. | - |
| Catherine D. Strader | M | 70 | 4 anni | |
| Jodie Morrison | F | 48 |
Cadent Therapeutics, Inc.
Cadent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Cadent Therapeutics, Inc. develops novel small molecule therapeutics to treat schizophrenia and other cognitive disorders. It focuses on modulating synaptic plasticity, the mechanism through which the brain builds and evolves the synaptic networks that carry out cognitive functions such as learning and memory. The company was founded by Kollol Pal, Frank S. Menniti, and Bertrand Leo Chenard in 2010 and is headquartered in Cambridge, MA. | 2 anni |
| Burkhard Blank | M | 69 | 5 anni | |
| Erin Campany | F | 57 | 4 anni | |
| Michael Samar | M | 51 | 3 anni | |
| Enrique Carrazana | M | 62 | 5 anni | |
| Benedict Osorio | M | 67 | 2 anni | |
| Michael Mulqueen | M | - |
Biotie Therapies, Inc.
| 4 anni |
| Anthony Caggiano | M | 54 | 16 anni | |
| Michael Rogers | M | 64 | 3 anni | |
| John McBride | M | 72 |
Cadent Therapeutics, Inc.
Cadent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Cadent Therapeutics, Inc. develops novel small molecule therapeutics to treat schizophrenia and other cognitive disorders. It focuses on modulating synaptic plasticity, the mechanism through which the brain builds and evolves the synaptic networks that carry out cognitive functions such as learning and memory. The company was founded by Kollol Pal, Frank S. Menniti, and Bertrand Leo Chenard in 2010 and is headquartered in Cambridge, MA. | 2 anni |
| Bob Dagher | M | 55 |
Cadent Therapeutics, Inc.
Cadent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Cadent Therapeutics, Inc. develops novel small molecule therapeutics to treat schizophrenia and other cognitive disorders. It focuses on modulating synaptic plasticity, the mechanism through which the brain builds and evolves the synaptic networks that carry out cognitive functions such as learning and memory. The company was founded by Kollol Pal, Frank S. Menniti, and Bertrand Leo Chenard in 2010 and is headquartered in Cambridge, MA. | 2 anni |
Statistiche
| Paese | Relazioni | % del totale |
|---|---|---|
| Canada | 20 | 58.82% |
| Stati Uniti | 14 | 41.18% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Christopher Kenney
- Contatti personali
